| Trial ID: | L1082 |
| Source ID: | NCT03321942
|
| Associated Drug: |
Treatment Group
|
| Title: |
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Mesenchymal Stem Cells|Chronic Kidney Diseases|Renal Interstitial Fibrosis
|
| Interventions: |
DRUG: Treatment group|DRUG: Control group
|
| Outcome Measures: |
Primary: serum creatinine, intravenous blood sampling, after 3 months of adipose tissue-derived mesenchymal stem cells treatment | Secondary: glomerular filtration rate, emission computed tomography, after 3 months of adipose tissue-derived mesenchymal stem cells treatment|apparent relaxation rate, blood oxygen level dependent magnetic resonance imaging, after 3 months of adipose tissue-derived mesenchymal stem cells treatment
|
| Sponsor/Collaborators: |
Sponsor: The Affiliated Hospital of Xuzhou Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-01-01
|
| Completion Date: |
2018-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2017-10-26
|
| Locations: |
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03321942
|
